The role of estrogen in osteoarthritis and lower back pain

UCB’s treat­ment can­di­dates for plaque pso­ri­a­sis and gen­er­al­ized myas­the­nia gravis have both bagged ap­provals in the US, ex­pand­ing cur­rent mar­ket op­por­tu­ni­ties and open­ing up new

No­var­tis’ re­or­ga­ni­za­tion is pay­ing off, CEO Vas Narasimhan told in­vestors at an event Thurs­day in Lon­don. The com­pa­ny raised its sales guid­ance through 2028 and